Royal Bank of Canada’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-212
Closed -$2K 6615
2025
Q1
$2K Sell
212
-117,144
-100% -$1.11M ﹤0.01% 6162
2024
Q4
$872K Buy
+117,356
New +$872K ﹤0.01% 3254
2024
Q3
Sell
-590
Closed -$7K 6360
2024
Q2
$7K Buy
590
+268
+83% +$3.18K ﹤0.01% 6043
2024
Q1
$7K Buy
322
+184
+133% +$4K ﹤0.01% 5864
2023
Q4
$1K Buy
138
+136
+6,800% +$986 ﹤0.01% 6346
2023
Q3
$0 Sell
2
-4
-67% ﹤0.01% 6558
2023
Q2
$1K Buy
6
+1
+20% +$167 ﹤0.01% 6497
2023
Q1
$2K Buy
5
+3
+150% +$1.2K ﹤0.01% 6358
2022
Q4
$2K Buy
+2
New +$2K ﹤0.01% 6435
2022
Q3
Sell
-1
Closed -$2K 6927
2022
Q2
$2K Hold
1
﹤0.01% 6447
2022
Q1
$3K Sell
1
-4
-80% -$12K ﹤0.01% 6885
2021
Q4
$24K Buy
5
+3
+150% +$14.4K ﹤0.01% 6182
2021
Q3
$15K Buy
2
+1
+100% +$7.5K ﹤0.01% 6283
2021
Q2
$12K Hold
1
﹤0.01% 6289
2021
Q1
$13K Hold
1
﹤0.01% 6167
2020
Q4
$7K Buy
+1
New +$7K ﹤0.01% 5963
2020
Q3
Hold
0
6096
2020
Q2
Hold
0
-$1K 6118
2020
Q1
Sell
-1
Closed -$9K 5890
2019
Q4
$9K Buy
+1
New +$9K ﹤0.01% 5567
2019
Q3
Hold
0
-$1K 5975
2019
Q2
Hold
0
5707
2018
Q4
Hold
0
5794
2018
Q3
Hold
0
6086
2018
Q2
Hold
0
5906
2018
Q1
Hold
0
5699
2017
Q4
Hold
0
5762
2017
Q3
Hold
0
5924